SECURITIES AND EXCHANGE COMMISSIONS
Washington, D.C. 20549
Form 8K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
DATE OF REPORT: September 6, 2006
CCA Industries, Inc.
(Exact Name of Registrant as Specified in Charter)
DELAWARE
(State or other jurisdiction of incorporation or organization)
2-85538-B
(Commission File Number)
1-31643
(IRS Employer Identification Number)
200 Murray Hill Parkway, East Rutherford, New Jersey 07073
(Address of principal executive offices, zip code)
(201) 330-1400
(Registrant’s telephone number including area code)
Page 1 of 4
Item 1.01 Entry into a Material Definitive Agreement
On August 29, 2006, the Company entered into a $25 million non-secured revolving Line of Credit with the Wells Fargo Bank, National Association for the fiscal period ending August 31, 2007.
A copy of the Agreement is annexed hereto as Exhibit “1”.
A copy of the Note is annexed hereto as Exhibit “2”.
A copy of the Corporate Resolution and Certification is annexed hereto as Exhibit “3”.
Item 8.01 Other Events
On August 28, 2006, the Company (CAW) entered into a Memorandum of Understanding with Competitive Technologies, Inc. (CTT).
CTT works with universities, companies and inventors all over the world to help bring their new technologically innovative products to the marketplace. CTT has agreed to match CAW with the new concepts that they have been exposed to in the health, beauty and consumer sectors.
A copy of the August 30th news release is annexed hereto as Exhibit “4.”
SIGNATURES
Pursuant to the requirements of the Securities Act of 1934, the registrant has duly cased this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: September 6, 2006
CCA Industries, Inc.
Registrant
By: Ira W. Berman
Ira W. Berman, Secretary
Page 2 of 4
Item 8.01 Other Events EXHIBIT “4”
For Competitive Technologies, Inc: For CCA Industries, Inc.
Jennifer Carberry, Ira W. Berman
Director of Marketing Chairman of the Board
Tel: 203-368-6044 Tel: (201) 935-3232
Email: jcarberry@competitivetech.net jcarberry@competitivetech.net Web: www.ccaindustries.com
Web: www.competitivetech.net
COMPETITIVE TECHNOLOGIES AND CCA INDUSTRIES TO PARTNER ON NEW PRODUCT INITIATIVES AND GLOBAL DISTRIBUTION CHANNELS
Fairfield, CT (August 30, 2006) – Competitive Technologies, Inc. (AMEX: CTT), a leader in intellectual property licensing, and CCA Industries, Inc. (AMEX: CAW), a manufacturer and marketer of health and beauty aids, have entered into a partnership to bring new products to market and expand CCA’s distribution channels outside North America. Under the agreement, CTT will provide unique health and consumer product technologies that fit with CCA’s customer segments, and will allow CCA to use CTT’s network to develop international distribution channels for CCA products.
“With CTT’s premium access to new technologies, developed by universities, companies and inventors throughout the world, we are constantly exposed to innovative products in the health, beauty and consumer sectors. We are confident that we will be able to successfully introduce to CCA some exciting new products to supplement their current offerings,” commented Dr. D. J. Freed, President and Chief Executive Officer of Competitive Technologies, Inc.
David Edell, Chief Executive Officer of CCA Industries, added, “Our partnership with CTT will enable us to expand our distribution on a global scale. By leveraging CTT’s international network, we are confident we can penetrate a variety of new markets with our existing product line. We are also very excited about augmenting our current offering with novel, exciting products.”
Competitive Technologies has a long track record of commercializing new technologies and has generated millions of dollars in licensing revenues for its clients. Some of the more notable technologies CTT has brought to market include the gallium arsenide laser, vitamin B12, Ethyol™ (an agent that reduces certain side effects of chemotherapy) and the homocysteine assay. In the consumer product segment, CTT is currently commercializing AccuSpeech’s EZSpeech ABI (American Business Idioms) software and Therapik®, a thermal therapy device that provides temporary relief of the pain and itching resulting from insect stings and bites.
About CCA Industries, Inc.
CCA Industries, Inc. (AMEX - CAW) manufactures and markets health and beauty aids, each under its individual brand name. The products include, principally, “Plus+White” toothpastes and teeth whiteners, “Sudden Change” anti-aging skin care products and “Scar Zone,” “Nutra Nail” nail growth treatments, “Mega-T” Green Tea diet aids, “Mega-T” chewing gum, “Mega-G” diet aids, “Hair Off” hair removal and depilatories, “Bikini Zone” medicated crème and gel for the bikini area, “Solar Sense” sun protection products, and “Cherry Vanilla” Perfume. For more information, please visit www.ccaindustries.com.
Page 3 of 4
About Competitive Technologies, Inc.
Competitive Technologies, established in 1968, is a full service technology transfer and licensing provider, focused on bringing the intellectual property assets of its clients to the marketplace. CTT specializes in identifying, developing and commercializing innovative technologies in a variety of areas, including life and physical sciences, electronics, and nanotechnologies. Through its global distribution platform, CTT maximizes the value of its clients’ intellectual property assets. For more information, please visit: www.competitivetech.net.
Statements about our future expectations, including development and regulatory plans, and all other statements in this press release, other than historical facts, are “forward-looking statements” within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. If and when used herein, the
words “may,” “will,” “should,” “anticipate,” “believe,” “intend,” “plan,” “expect,” “estimate,” “approximate,” and similar expressions, as they relate to us or our business or management, are intended to identify such forward-looking statements. These statements involve risks and uncertainties related to our ability to obtain rights to market technologies, market acceptance of and competition for our licensed technologies, growth strategies, operating performance, industry trends, and other risks and uncertainties inherent in our business, including those set forth in Item 7 under the caption “Risk Factors,” in our most recent Annual Report on Form 10-K for the year ended July 31, 2005, filed with the Securities and Exchange Commission (“SEC”) on October 13, 2005, and other factors that may be described in our other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.
Page 4 of 4
